Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01314963 · ClinicalTrials.gov registry record · NA
Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01314963: Completed NA study, sponsored by Stanford University.
NCT01314963 is a NA study that has completed, run by Stanford University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01314963, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study evaluates the ability of a prototype intraoperative handheld gamma camera (pIHGC) to image (detect) sentinel lymph nodes (SLNs) in melanoma and breast cancer during surgical excision, as compared to standard of care intraoperative gamma probes (GP). The unit of study in this trial was SNLs rather individual participants. Each device was assessed for relative node detection sensitivity (S) of those SLNs.
Interventions
- DEVICE Prototype intraoperative handheld gamma camera (pIHGC)
- DEVICE Lymphoscintigraphy with intraoperative gamma probes (GP)
- RADIATION radioactive Tc99M
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-06 |
| Est. Completion | 2012-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01314963
The ClinicalTrials.gov registry entry for NCT01314963 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Prototype intraoperative handheld gamma camera (pIHGC) is the first listed.
NCT01314963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01314963 about?
NCT01314963 is a clinical study titled "Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy". This study evaluates the ability of a prototype intraoperative handheld gamma camera (pIHGC) to image (detect) sentinel lymph nodes (SLNs) in melanoma and breast cancer during surgical excision, as compared to standard of care intraoperative gamma probes (GP). The unit of study in this trial was SNL...
What is the current status of trial NCT01314963?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2008-06. Estimated completion is 2012-07-26.
What interventions are being tested in trial NCT01314963?
The interventions under investigation include: Prototype intraoperative handheld gamma camera (pIHGC) (DEVICE), Lymphoscintigraphy with intraoperative gamma probes (GP) (DEVICE), radioactive Tc99M (RADIATION).
Who is sponsoring clinical trial NCT01314963?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.